Yanping Li

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Topics

Squamous Cell Carcinoma

Tyrosine Kinase

Hepatitis C Virus

Endoplasmic Reticulum Stress

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Bo Yang, Yanni Quan, Wuli Zhao, Yingjie Ji, Xiaotang Yang, Jianrui Li, Yi Li, Xiujun Liu, Ying Wang, Yanping Li
Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Bo Yang, Yanni Quan, Wuli Zhao, Yingjie Ji, Xiaotang Yang, Jianrui Li, Yi Li, Xiujun Liu, Ying Wang, Yanping Li
Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Bo Yang, Yanni Quan, Wuli Zhao, Yingjie Ji, Xiaotang Yang, Jianrui Li, Yi Li, Xiujun Liu, Ying Wang, Yanping Li
Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Yixuan Wang, Jianrui Li, Jiali Tan, Bo Yang, Yanni Quan, Zong-Gen Peng, Yanping Li, Zhuo-Rong Li
Design, Synthesis, and Biological Evaluation of 2-((4-Bisarylmethyl-piperazin-1-yl)methyl)benzonitrile Derivatives as HCV Entry Inhibitors. Journal of medicinal chemistry 65 (3) (2022)
Xinbei Jiang, Jiali Tan, Yixuan Wang, Jinhua Chen, Jianrui Li, Zhi Jiang, Yanni Quan, Jie Jin, Yuhuan Li, Shan Cen, Yanping Li, Zong-Gen Peng, Zhuo-Rong Li
2-((4-Arylpiperazin-1-yl)methyl)benzonitrile Derivatives as Orally Available Inhibitors of Hepatitis C Virus with a Novel Mechanism of Action. Journal of medicinal chemistry 63 (11) (2020)